Research Associate II In Vivo

Novel Analgesic Breakthrough: Xinhua Pharmaceutical’s Class 1 Drug LXH-2103 Secures Clinical Approval with Medicilon’s Preclinical Support

This role will be responsible for study design, execution, data interpretation, client communication, and development of new in vivo models and capabilities.
The ideal candidate has strong hands-on experience with animal models, particularly oncology and emerging therapeutic modalities, and is comfortable working in a fast-paced CRO environment where scientific quality, timelines, and client communication are equally important.

Associate Scientist Preclinical Pharmacology (In Vivo & In Vitro)

Novel Analgesic Breakthrough: Xinhua Pharmaceutical’s Class 1 Drug LXH-2103 Secures Clinical Approval with Medicilon’s Preclinical Support

This role will be responsible for study design, execution, data interpretation, client communication, and development of new in vivo models and capabilities.
The ideal candidate has strong hands-on experience with animal models, particularly oncology and emerging therapeutic modalities, and is comfortable working in a fast-paced CRO environment where scientific quality, timelines, and client communication are equally important.

Research Scientist I Pharmacology

Novel Analgesic Breakthrough: Xinhua Pharmaceutical’s Class 1 Drug LXH-2103 Secures Clinical Approval with Medicilon’s Preclinical Support

This role will be responsible for study design, execution, data interpretation, client communication, and development of new in vivo models and capabilities.
The ideal candidate has strong hands-on experience with animal models, particularly oncology and emerging therapeutic modalities, and is comfortable working in a fast-paced CRO environment where scientific quality, timelines, and client communication are equally important.

Senior Scientist, In Vivo Pharmacology

Novel Analgesic Breakthrough: Xinhua Pharmaceutical’s Class 1 Drug LXH-2103 Secures Clinical Approval with Medicilon’s Preclinical Support

This role will be responsible for study design, execution, data interpretation, client communication, and development of new in vivo models and capabilities.
The ideal candidate has strong hands-on experience with animal models, particularly oncology and emerging therapeutic modalities, and is comfortable working in a fast-paced CRO environment where scientific quality, timelines, and client communication are equally important.

Search Medicilon

Preclinical CRO

Medicilon Congratulates : MindRank AI-Developed Oral GLP-1 MDR-001 Secures Up to RMB 1.75 Billion Exclusive Commercialization Deal with Sunshine Mandi

Preclinical CRO

A Note of Appreciation, A Mark of Recognition | Medicilon Supports Partner Tasly in Obtaining Clinical Trial Approval for TSL2402 Tablets

BIOJAPAN 2026

Contact Medicilon

Name(Required)
Address(Required)